CHF 76.62
(0.39%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 2.24 Billion USD | 33.37% |
2022 | 1.72 Billion USD | -2.11% |
2021 | 1.75 Billion USD | 57.58% |
2020 | 1.11 Billion USD | -9.05% |
2019 | 1.2 Billion USD | -9.39% |
2018 | 1.34 Billion USD | 10.45% |
2017 | 1.2 Billion USD | -4.97% |
2016 | 1.28 Billion USD | -25.1% |
2015 | 1.72 Billion USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 676 Million USD | 42.02% |
2024 Q2 | 641 Million USD | -5.18% |
2023 Q2 | 261 Million USD | 0.38% |
2023 Q3 | 285 Million USD | 9.2% |
2023 Q4 | 215 Million USD | -24.56% |
2023 Q1 | 260 Million USD | 2788.89% |
2023 FY | - USD | 33.37% |
2022 Q3 | 444 Million USD | -11.02% |
2022 FY | - USD | -2.11% |
2022 Q1 | 492 Million USD | 191.12% |
2022 Q4 | 9 Million USD | -97.97% |
2022 Q2 | 499 Million USD | 1.42% |
2021 FY | - USD | 57.58% |
2021 Q4 | 169 Million USD | -61.5% |
2021 Q3 | 439 Million USD | -6.0% |
2021 Q2 | 467 Million USD | 10.14% |
2021 Q1 | 424 Million USD | 214.07% |
2020 Q1 | 337 Million USD | 22.99% |
2020 FY | - USD | -9.05% |
2020 Q4 | 135 Million USD | -53.61% |
2020 Q3 | 291 Million USD | 547.69% |
2020 Q2 | -65 Million USD | -119.29% |
2019 Q2 | 289 Million USD | 0.35% |
2019 Q1 | 288 Million USD | 416.48% |
2019 FY | - USD | -9.39% |
2019 Q4 | 274 Million USD | -22.82% |
2019 Q3 | 355 Million USD | 22.84% |
2018 Q2 | 30 Million USD | -92.55% |
2018 FY | - USD | 10.45% |
2018 Q4 | -91 Million USD | 68.73% |
2018 Q3 | -291 Million USD | -1070.0% |
2018 Q1 | 402.5 Million USD | 36.44% |
2017 Q4 | 295 Million USD | 0.0% |
2017 FY | - USD | -4.97% |
2016 FY | - USD | -25.1% |
2015 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
COLTENE Holding AG | 23.8 Million CHF | -9318.585% |
SKAN Group AG | 50.14 Million CHF | -4371.123% |
Straumann Holding AG | 502.86 Million CHF | -345.843% |
Tecan Group AG | 205.57 Million CHF | -990.605% |
IVF Hartmann Holding AG | 23.36 Million CHF | -9494.728% |
Ypsomed Holding AG | 161.77 Million CHF | -1285.867% |